Pharmaron Beijing company profile

300759 · SZSE · CNY

Compare Pharmaron Beijing
¥38.50Change from previous close: −3.39%Absolute change: −¥1.35

Close · November 20, 2026

Company profile

Pharmaron Beijing has 25,088 employees and is headquartered in Beijing, China.

Laboratory Services, the first of the five segments through which Pharmaron Beijing Co., Ltd. and its subsidiaries operate, provides chemistry and biological science services for small molecule drugs, oligonucleotides, peptides, antibodies, antibody-drug conjugates and cell and gene therapy products. The company also runs small molecule CDMO services, covering API process development and production, formulation and analytical development, alongside clinical research and macromolecular and cell and gene therapy services that span drug discovery through to production. Its customers are located in North America, Europe, Mainland China and across Asia.

In the fiscal year ended December 2025, the company reported revenue of 14.1 billion yuan, up 14.8% from the previous year, and net profit of 1.7 billion yuan. It had 25,088 employees and is headquartered in Beijing, where it was incorporated in 2004.

Company facts

Industry
Biotechnology
Country
China
Headquarters
Building 1, 100176, Beijing
Employees
25,088
Chief executive
Boliang Lou
Founded
2004
Fiscal year
January - December
Listing
300759 · SZSE
Currency
CNY
ISIN
CNE100003JW4

Pharmaron Beijing and its competitors

The most similar companies by business and size

CompanyCountryMarket capEmployeesOperating marginP/E (trailing 12 months)
Pharmaron Beijing300759China$10.59B25,08814.0%39.3
Sino Biopharmaceutical1177Hong Kong SAR China$11.65B22,83828.2%34.2
ALTEOGEN196170South Korea$9.05B18147.2%97.1
Haisco Pharmaceutical Group002653China$8.97B5,59721.1%44.1
Genscript Biotech1548Hong Kong SAR China$8.77B6,13514.9%—
Sichuan Kelun-Biotech Biopharmaceutical6990Hong Kong SAR China$12.15B2,300-0.2%—

Competitors: same or related industry, same region first, then the closest market capitalization. Market cap converted into US dollars at the latest exchange rates; P/E over the last 12 months, not shown when negative.

Compare Pharmaron Beijing with its competitors